TickerFacts.

Exelixis, Inc. (EXEL): EPS (Diluted)

Annual figures by period end, from SEC filings.

$2.78
Year ended 2026-01-02, Fiscal 2025
+70.6%
3-year compound annual growth
+51.4%
5-year compound annual growth
2009-12-31: -$1.262010-12-31: -$0.852011-12-31: $0.582012-12-31: -$0.922013-12-31: -$1.332016-01-01: -$0.772016-12-30: -$0.282017-12-29: $0.492018-12-28: $2.212020-01-03: $1.022021-01-01: $0.352021-12-31: $0.722022-12-30: $0.562023-12-29: $0.652025-01-03: $1.762026-01-02: $2.78$2.78
2009-12-31 EPS (Diluted) (USD per share) 2026-01-02
Period endedEPS (Diluted)Change YoYSource filing
2026-01-02, Fiscal 2025$2.78+58.0%2026-02-10, From 2025-01-04
2025-01-03, Fiscal 2024$1.76+170.8%2026-02-10, From 2023-12-30
2023-12-29$0.65+16.1%2026-02-10, From 2022-12-31
2022-12-30$0.56-22.2%2025-02-11, From 2022-01-01
2021-12-31$0.72+105.7%2024-02-06, From 2021-01-02
2021-01-01, Fiscal 2020$0.35-65.7%2023-02-07, From 2020-01-04
2020-01-03, Fiscal 2019$1.02-53.8%2022-02-18, From 2018-12-29
2018-12-28$2.21+351.0%2021-02-11, From 2018-01-01
2017-12-29$0.49n/m2020-02-25, From 2016-12-31
2016-12-30-$0.28n/m2019-02-22, From 2016-01-02
2016-01-01, Fiscal 2015-$0.77n/a2018-02-26, From 2015-01-03
No annual figure between 2013-12-31 and 2016-01-01.
2013-12-31-$1.33n/m2014-02-20, From 2013-01-01
2012-12-31-$0.92n/m2014-02-20, From 2012-01-01
2011-12-31$0.58n/m2014-02-20, From 2011-01-01
2010-12-31-$0.85n/m2013-02-21, From 2010-01-01
2009-12-31-$1.26n/a2012-02-22, From 2009-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Exelixis, Inc. (EXEL)2026-01-02$2.78+58.0%
Qiagen N.V. (QGEN)2025-12-31$1.94+424.3%
Moderna, Inc. (MRNA)2025-12-31-$7.26n/m
Neurocrine Biosciences Inc (NBIX)2025-12-31$4.67+41.9%
Halozyme Therapeutics, Inc. (HALO)2025-12-31$2.56-25.4%
Bio-Techne Corp (TECH)2026-06-30$1.16+152.2%
Novavax Inc (NVAX)2025-12-31$2.58n/m
BioCryst Pharmaceuticals Inc (BCRX)2025-12-31$1.21n/m
Repligen Corp (RGEN)2025-12-31$0.86n/m

Compare EXEL, QGEN, MRNA, NBIX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗